Pontus Hegardt

Nitric-Oxide-Dependent Systemic Immunosuppression in Animals with Progressively Growing Malignant Gliomas

Pontus Hegardt, Bengt Widegren, Hans-Olov Sjögren · Cellular Immunology · 2000 · 38 citations

Neuro-oncology, Nitric-oxide-dependent Systemic Immunosuppression, Medicine +9

Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma

Pontus Hegardt, Bengt Widegren, Li Li et al. · Cancer Immunology Immunotherapy · 2001 · 31 citations · Full text

Inflammation, Cytokine, Cancer Immunosurveillance +9

Inhibition of Inducible Nitric Oxide Synthase Enhances Anti‐tumour Immune Responses in Rats Immunized with IFN‐<i>γ</i>‐Secreting Glioma Cells

Wiaam Badn, Pontus Hegardt, Maria Fellert et al. · Scandinavian Journal of Immunology · 2007 · 25 citations · Full text

Nitric Oxide, Immunology, Innate Immunity +18

Enhanced expression of iNOS intratumorally and at the immunization site after immunization with IFNγ-secreting rat glioma cells

Anna Johansson, Pontus Hegardt, Shorena Janelidze et al. · Journal of Neuroimmunology · 2002 · 22 citations

Cancer Immunosurveillance, Medicine, Immunology +9

Discovery and Early Clinical Development of Isobutyl 1-[8-Methoxy-5-(1-oxo-3<i>H</i>-isobenzofuran-5-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]cyclopropanecarboxylate (LEO 39652), a Novel “Dual-Soft” PDE4 Inhibitor for Topical Treatment of Atopic Dermatitis

Jens Larsen, Maja Lambert, Henrik Pettersson et al. · Journal of Medicinal Chemistry · 2020 · 16 citations · Full text